Puma Biotechnology, Inc. (PBYI)
9.83
-0.69
(-6.56%)
USD |
NASDAQ |
Oct 16, 16:00
9.83
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash and Short Term Investments (Quarterly) : 93.90M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.90M |
| March 31, 2026 | 103.64M |
| December 31, 2025 | 99.62M |
| September 30, 2025 | 96.48M |
| June 30, 2025 | 98.12M |
| March 31, 2025 | 93.17M |
| December 31, 2024 | 100.96M |
| September 30, 2024 | 96.72M |
| June 30, 2024 | 96.83M |
| March 31, 2024 | 107.16M |
| December 31, 2023 | 95.94M |
| September 30, 2023 | 85.03M |
| June 30, 2023 | 74.44M |
| March 31, 2023 | 71.22M |
| December 31, 2022 | 81.07M |
| September 30, 2022 | 77.96M |
| June 30, 2022 | 60.75M |
| March 31, 2022 | 73.91M |
| December 31, 2021 | 90.96M |
| September 30, 2021 | 96.39M |
| June 30, 2021 | 117.82M |
| March 31, 2021 | 117.90M |
| December 31, 2020 | 102.24M |
| September 30, 2020 | 117.87M |
| June 30, 2020 | 116.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 109.40M |
| December 31, 2019 | 120.49M |
| September 30, 2019 | 110.44M |
| June 30, 2019 | 117.66M |
| March 31, 2019 | 150.40M |
| December 31, 2018 | 165.42M |
| September 30, 2018 | 127.95M |
| June 30, 2018 | 134.51M |
| March 31, 2018 | 78.55M |
| December 31, 2017 | 81.70M |
| September 30, 2017 | 106.34M |
| June 30, 2017 | 151.65M |
| March 31, 2017 | 193.98M |
| December 31, 2016 | 229.48M |
| September 30, 2016 | 108.93M |
| June 30, 2016 | 143.79M |
| March 31, 2016 | 181.21M |
| December 31, 2015 | 215.89M |
| September 30, 2015 | 247.78M |
| June 30, 2015 | 282.37M |
| March 31, 2015 | 310.33M |
| December 31, 2014 | 141.33M |
| September 30, 2014 | 153.86M |
| June 30, 2014 | 178.35M |
| March 31, 2014 | 196.11M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 38.41M |
| Arcutis Biotherapeutics, Inc. | 238.86M |
| Olema Pharmaceuticals, Inc. | 461.07M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |